Koordination und Qualität im Gesundheitswesen

Scott, A., Shiell, A., and King, M. (1996): Is general practitioner decision making associated
with patient socio-economic status? Social Sciences and Medicine, Vol. 42, S. 35-46.
Smith, R. (2002): In search of “non-disease”. British Medical Journal, Vol. 324, S. 883-885.
Soumerai, S.B. and Avorn, J. (1986): Economic and policy analysis of university-based drug
„detailing“. Medical Care, Vol. 24, S. 313-331.
Stafford, R.S., Furberg, C.D., Finkelstein, S.N., Cockburn, I.M., Alehegn, T., and Ma, J. (2004):
Impact of clinical trial results on national trends in α-blocker prescribing, 1996-2002. Journal
of the American Medical Association; Vol. 291, S. 54-62.
Statistisches Bundesamt (2002): Gesundheit, Ausgaben 1992-2000, Presseexemplar,
Wiesbaden.
Statistisches Bundesamt (2004a): Gesundheitsausgaben 2001 und 2002 nach Leistungsausgaben
und Ausgabenträgern, Wiesbaden.
Statistisches Bundesamt (2004b): Fortschreibung des Bevölkerungsstandes, in: Gesundheitsberichterstattung
des Bundes, www.gbe-bund.de.
Steinman, M.A., Landefeld, C.S. and Gonzales, R. (2003): Predictors of broad-spectrum antibiotic
prescribing for acute prespiratory tract infections in adult primary care. Journal of the
American Medical Association, Vol. 289, S. 719-725.
Steinman, M.A., Shlipak, M.G. and McPhee, S.J. (2001): Of principles and pens: attitudes and
practices of medicine housestaff toward pharmaceutical industry promotion. American Journal
of Medicine, Vol. 110, S. 551-517.
Stern, J.M. and Simes, R.J. (1997): Publication bias: evidence of delayed publication in a cohort
study of clinical research projects. British Medical Journal, Vol. 315, S. 640-645.
Sterzel, A. (2002): Deregulierung des Arzneimittelvertriebs in Deutschland. Versandapotheke
als Reformoption? Eine ökonomische Analyse, Berlin.
Stille, G. (1994): Der Weg der Arznei. Von der Materia Medica zur Pharmakologie, Karlsruhe.
Stocks, N.P., Ryan, P., McElroy, H., and Allan, J. (2004): Statin prescribing in Australia: socioeconomic
and sex differences. A cross-sectional study. Medical Journal of Australia,
Vol. 180, S. 229-231.
Stolze, C. (2003): Potente Tipps von Pelé. Die Zeit, Nr. 38 vom 11. September 2003, S. 39.
Strull, W.M., Lo, B., Charles, G. (1984): Do patients want to participate in medical decision
making? Journal of the American Medical Association, Vol. 252, S. 2990-2994.
Szecsenyi, J. (2003): Influence of attitudes and behaviour of GPs on prescribing costs. Quality
and Safety in Health Care, Vol. 12, S. 6-7.
Tang, W.H., Girod, J.P., Lee, M.J., Starling, R.C., Young, J.B., Van Lente, F. and Francis, G.S.
(2003): Plasma B-type natriuretic peptide levels in ambulatory patients with established
chronic symptomatic systolic heart failure. Circulation, Vol. 108, S. 2964-2966.
Task Force zur Verbesserung der Standortbedingungen und der Innovationsmöglichkeiten der
pharmazeutischen Industrie in Deutschland (2004): Bericht und Aktionsplan der Task Force,
Berlin; www.bmgs.bund.de/downloads/BerichtTaskForce_Komplettfassung.pdf
(18.04.2005)
THE EURO-MED-STAT GROUP (2003): EURO-MED-STAT; Monitoring expenditure and
utilization of medicinal products in the European countries: a Public Health approach. European
Journal of Public Health, Vol. 13, Nr. 3, S. 95-100.
756